News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
826,172 Results
Type
Article (78822)
Company Profile (646)
Press Release (746704)
Section
Business (229994)
Career Advice (3956)
Deals (39419)
Drug Delivery (128)
Drug Development (89767)
Employer Resources (198)
FDA (17892)
Job Trends (17171)
News (391372)
Policy (39140)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2992)
Academic (2)
Accelerated approval (5)
Adcomms (29)
Allergies (88)
Alliances (56355)
ALS (93)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (141)
Approvals (17857)
Artificial intelligence (279)
Autoimmune disease (22)
Automation (14)
Bankruptcy (401)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (441)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (274)
Cancer (2174)
Cardiovascular disease (189)
Career advice (3377)
Career pathing (33)
CAR-T (161)
Cell therapy (457)
Cervical cancer (21)
Clinical research (72240)
Collaboration (842)
Compensation (482)
Complete response letters (30)
COVID-19 (2858)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2038)
Decentralized trials (2)
Denatured (43)
Depression (51)
Diabetes (275)
Diagnostics (6883)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (127)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (93)
Earnings (94902)
Editorial (40)
Employer branding (25)
Employer resources (167)
Events (128621)
Executive appointments (692)
FDA (19080)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (751)
Gene editing (111)
Generative AI (28)
Gene therapy (327)
GLP-1 (824)
Government (5100)
Grass and pollen (5)
Guidances (49)
Healthcare (20872)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (131)
Indications (27)
Infectious disease (3007)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (91)
Interviews (777)
IPO (17750)
IRA (51)
Job creations (5037)
Job search strategy (2744)
Kidney cancer (10)
Labor market (38)
Layoffs (540)
Leadership (21)
Legal (10014)
Liver cancer (76)
Lung cancer (317)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (305)
MASH (68)
Medical device (14569)
Medtech (14574)
Mergers & acquisitions (22149)
Metabolic disorders (731)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (104)
Neuropsychiatric disorders (31)
Neuroscience (2028)
NextGen: Class of 2025 (7653)
Non-profit (5077)
Northern California (2522)
Now hiring (38)
Obesity (397)
Opinion (270)
Ovarian cancer (75)
Pain (90)
Pancreatic cancer (79)
Parkinson's disease (148)
Partnered (21)
Patents (221)
Patient recruitment (101)
Peanut (51)
People (64400)
Pharmaceutical (134)
Pharmacy benefit managers (21)
Phase I (22307)
Phase II (31459)
Phase III (23737)
Pipeline (1107)
Podcasts (122)
Policy (141)
Postmarket research (3348)
Preclinical (9888)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (407)
Real estate (7233)
Recruiting (75)
Regulatory (26204)
Reports (57)
Research institute (2655)
Resumes & cover letters (626)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (84)
Service/supplier (26)
Sickle cell disease (57)
Southern California (2192)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4259)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (14)
The Weekly (77)
United States (22826)
Vaccines (775)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (38)
Worklife (19)
Date
Today (62)
Last 7 days (700)
Last 30 days (2747)
Last 365 days (36036)
2025 (8968)
2024 (37936)
2023 (42567)
2022 (53928)
2021 (58723)
2020 (57665)
2019 (51323)
2018 (39108)
2017 (37002)
2016 (38037)
2015 (44094)
2014 (38982)
2013 (35311)
2012 (37265)
2011 (37285)
2010 (37199)
Location
Africa (1228)
Alabama (56)
Alaska (7)
Arizona (246)
Arkansas (14)
Asia (48957)
Australia (8454)
California (5867)
Canada (1923)
China (511)
Colorado (264)
Connecticut (281)
Delaware (138)
Europe (111513)
Florida (854)
Georgia (209)
Hawaii (1)
Idaho (64)
Illinois (580)
India (28)
Indiana (316)
Iowa (10)
Japan (147)
Kansas (107)
Kentucky (27)
Louisiana (13)
Maine (69)
Maryland (908)
Massachusetts (4547)
Michigan (234)
Minnesota (399)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (69)
New Jersey (1679)
New Mexico (31)
New York (1674)
North Carolina (1073)
North Dakota (8)
Northern California (2522)
Ohio (207)
Oklahoma (15)
Oregon (45)
Pennsylvania (1305)
Puerto Rico (10)
Rhode Island (30)
South America (1606)
South Carolina (19)
South Dakota (1)
Southern California (2192)
Tennessee (98)
Texas (882)
Utah (175)
Virginia (152)
Washington D.C. (65)
Washington State (563)
West Virginia (3)
Wisconsin (61)
826,172 Results for "biotronik se and co kg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KGKARL STORZ to provide up to $20 million in bridge financing
Asensus Surgical, Inc. announced that it has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG, an independent, family-owned global medical technology company to engage in diligence and negotiations regarding the terms of a potential transaction whereby KARL STORZ may acquire Asensus.
April 3, 2024
·
9 min read
Press Releases
BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
August 15, 2024
·
3 min read
BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter
BIOTRONIK is proud to introduce the Micro Rx™ catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions.
February 8, 2024
·
3 min read
Press Releases
EG 427 raises €27 million in successful Series B co-led by Andera Partners and Bpifrance to finance on-going clinical study and platform development
February 20, 2025
·
6 min read
Press Releases
Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
November 6, 2024
·
7 min read
Business
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics
Secarna Pharmaceuticals GmbH & Co. KG and Orbit Discovery Ltd. today announced that they have entered into a collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide (ASO) therapeutics.
May 28, 2024
·
2 min read
Business
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
The Supervisory Board of Evotec SE has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer, effective 01 July 2024.
April 23, 2024
·
6 min read
BIOTRONIK’s DX Technology Reaches Significant Milestone: 100,000 DX Devices Implanted
BIOTRONIK announced the milestone achievement of 100,000 implanted single lead implantable cardioverter-defibrillators equipped with DX Technology enabling direct atrial sensing for atrial fibrillation detection and monitoring.
January 29, 2024
·
4 min read
BioForest
Evotec SE: Invitation to Conference Call - Jan 22, 2024
Evotec SE is going to hold a conference call to provide a statement as well as a business update on Monday, 22 January 2024.
January 22, 2024
·
3 min read
Press Releases
Merck’s Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma
December 9, 2024
·
9 min read
1 of 82,618
Next
